Drug intelligence / Profile preview

sulfapyridine

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral
01

Overview

Sulfapyridine is a sulfonamide antibiotic and anti-inflammatory small molecule that was historically used to treat dermatitis herpetiformis (Duhring’s disease), benign mucous membrane pemphigoid, pyoderma gangrenosum, rheumatoid arthritis, ulcerative colitis, Crohn’s disease, and systemic lupus erythematosus[1][2][5]. Its primary mechanism of action is as a competitive inhibitor of the bacterial enzyme dihydropteroate synthase, which blocks folic acid synthesis in susceptible bacteria by interfering with the processing of para-aminobenzoic acid (PABA)[2][7]. Sulfapyridine is also a major metabolite of sulfasalazine. It has been discontinued for marketing in many regions due to safety concerns and the availability of better alternatives[1][3].

Brand names
Dagenan
Other names
sulphapyridine
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on sulfapyridine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulfapyridine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call